UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

CPT: pharmacometrics and systems pharmacology, 2017-02, Vol.6 (2), p.87-109

2017

Volltextzugriff (PDF)

New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale

Antimicrobial agents and chemotherapy, 2014-12, Vol.58 (12), p.7324-7330

2014

Volltextzugriff (PDF)

Development and performance of npde for the evaluation of time-to-event models

Pharmaceutical research, 2018-02, Vol.35 (2), p.30-15, Article 30

2018

Volltextzugriff (PDF)

dfpk: An R-package for Bayesian dose-finding designs using pharmacokinetics (PK) for phase I clinical trials

Computer methods and programs in biomedicine, 2018-04, Vol.157, p.163-177

2018

Volltextzugriff (PDF)

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis

Annals of the rheumatic diseases, 2008-04, Vol.67 (4), p.478-484

2008

Volltextzugriff (PDF)

STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling

Genes and immunity, 2010-07, Vol.11 (5), p.432-438

2010

Volltextzugriff (PDF)

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

British journal of clinical pharmacology, 2007-11, Vol.64 (5), p.603-612

2007

Volltextzugriff (PDF)

Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members

CPT: pharmacometrics and systems pharmacology, 2013-06, Vol.2 (6), p.1-2

2013

Volltextzugriff (PDF)

PharmML in Action: an Interoperable Language for Modeling and Simulation

CPT: pharmacometrics and systems pharmacology, 2017-10, Vol.6 (10), p.651-665

2017

Volltextzugriff (PDF)

Combined Analysis of Phase I and Phase II Data to Enhance the Power of Pharmacogenetic Tests

CPT: pharmacometrics and systems pharmacology, 2016-03, Vol.5 (3), p.123-131

2016

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians

Clinical pharmacology and therapeutics, 2012-05, Vol.91 (5), p.777-786

2012

Volltextzugriff (PDF)

Bioavailability of diazepam after intramuscular injection of its water‐soluble prodrug alone or with atropine–pralidoxime in healthy volunteers

British journal of pharmacology, 2009-08, Vol.157 (8), p.1390-1397

2009

Volltextzugriff (PDF)

White Paper: Landscape on Technical and Conceptual Requirements and Competence Framework in Drug/Disease Modeling and Simulation

CPT: pharmacometrics and systems pharmacology, 2013-05, Vol.2 (5), p.1-8

2013

Volltextzugriff (PDF)

STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling

Genes and immunity, 2010-07, Vol.11 (5), p.446-446

2010

Volltextzugriff (PDF)

Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients

Antimicrobial agents and chemotherapy, 2014-12, Vol.58 (12), p.7331-7339

2014

Volltextzugriff (PDF)

Extrapolation bayésienne de la préclinique à la clinique

Revue d'épidémiologie et de santé publique, 2021-06, Vol.69, p.S13-S13

2021

Volltextzugriff (PDF)

Taking Kinetic Evaluations of Degradation Data to the Next Level with Nonlinear Mixed-Effects Models

Environments (Basel, Switzerland), 2021-08, Vol.8 (8), p.71

2021

Volltextzugriff (PDF)

dfpk: An R-package for Bayesian dose-finding designs using pharmacokinetics (PK) for phase I clinical trials

Computer methods and programs in biomedicine, 2018-04, Vol.157, p.163-177

2018

Volltextzugriff (PDF)

New Colistin Population Pharmacokinetic Data in Critically Ill Patients Suggesting an Alternative Loading Dose Rationale

Antimicrobial agents and chemotherapy, 2014-12, Vol.58 (12), p.7324-7330

2014

Volltextzugriff (PDF)

Population kinetics of factor VIII in mild hemophilia A patients following desmopressin intravenous administration

Fundamental & clinical pharmacology, 2017, Vol.31, p.18-18

2017

Volltextzugriff (PDF)

EVALUATION OF TESTS BASED ON INDIVIDUAL VERSUS POPULATION MODELING TO COMPARE DISSOLUTION CURVES

Journal of biopharmaceutical statistics, 2001-01, Vol.11 (3), p.107-123

2001

Volltextzugriff (PDF)

Rapid and simple micromethod for the quantification of fluindione in human plasma using high-performance liquid chromatography

Journal of chromatography. B, Biomedical sciences and applications, 1998-04, Vol.707 (1), p.169-173

1998

Volltextzugriff (PDF)

Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR

Journal of controlled release, 1999-05, Vol.59 (2), p.197-205

1999

Volltextzugriff (PDF)

Cerebral uptake of mefloquine enantiomers with and without the P‐gp inhibitor elacridar (GF1210918) in mice

British journal of pharmacology, 2004-04, Vol.141 (7), p.1214-1222

2004

Volltextzugriff (PDF)

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development

CPT: pharmacometrics and systems pharmacology, 2015-06, Vol.4 (6), p.316-319

2015

Volltextzugriff (PDF)

1 – 25 von 226

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(195)
Mit Volltextzugriff
(201)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(124)
Physics
(86)
Life Sciences & Biomedicine
(80)
Humans
(64)
Physical Sciences
(46)
Male
(38)
Female
(35)
High Energy Physics - Experiment
(29)
Nuclear Experiment
(28)
Biological And Medical Sciences
(27)
Medical Sciences
(27)
Physics, Nuclear
(26)
Pharmacology & Pharmacy
(25)
Life Sciences
(21)
High Energy Physics - Phenomenology
(18)
Pharmacology. Drug Treatments
(18)
Physics, Particles & Fields
(18)
Middle Aged
(17)
Ophthalmology
(15)
Adult
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale

Development and performance of npde for the evaluation of time-to-event models

dfpk: An R-package for Bayesian dose-finding designs using pharmacokinetics (PK) for phase I clinical trials

A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis

STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members

PharmML in Action: an Interoperable Language for Modeling and Simulation

Combined Analysis of Phase I and Phase II Data to Enhance the Power of Pharmacogenetic Tests

Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians

Bioavailability of diazepam after intramuscular injection of its water‐soluble prodrug alone or with atropine–pralidoxime in healthy volunteers

White Paper: Landscape on Technical and Conceptual Requirements and Competence Framework in Drug/Disease Modeling and Simulation

STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling

Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients

Extrapolation bayésienne de la préclinique à la clinique

Taking Kinetic Evaluations of Degradation Data to the Next Level with Nonlinear Mixed-Effects Models

dfpk: An R-package for Bayesian dose-finding designs using pharmacokinetics (PK) for phase I clinical trials

New Colistin Population Pharmacokinetic Data in Critically Ill Patients Suggesting an Alternative Loading Dose Rationale

Population kinetics of factor VIII in mild hemophilia A patients following desmopressin intravenous administration

EVALUATION OF TESTS BASED ON INDIVIDUAL VERSUS POPULATION MODELING TO COMPARE DISSOLUTION CURVES

Rapid and simple micromethod for the quantification of fluindione in human plasma using high-performance liquid chromatography

Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR

Cerebral uptake of mefloquine enantiomers with and without the P‐gp inhibitor elacridar (GF1210918) in mice

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development

Suchergebnisse filtern